CD7 (T-Cell Leukemia Marker) [B-F12]

Clear

Summary

Recognizes a protein of 40kDa, identified as CD7 (also known as gp40, Leu9). CD7 is a member of the immunoglobulin gene superfamily. Its N-terminal amino acids 1-107 are highly homologous to Ig kappa-L chains whereas the carboxyl-terminal region of the extracellular domain is proline-rich and has been postulated to form a stalk from which the Ig domain projects. CD7 is expressed on the majority of immature and mature T-lymphocytes, and T cell leukemia. It is also found on natural killer cells, a small subpopulation of normal B cells and on malignant B cells. Cross-linking surface CD7 positively modulates T cell and NK cell activity as measured by calcium fluxes, expression of adhesion molecules, cytokine secretion and proliferation. CD7 associates directly with phosphoinositol 3'-kinase. CD7 ligation induces production of D-3 phosphoinositides and tyrosine phosphorylation.

Product Properties & Targets

Host
Species Reactivity
Isotype
Cellular Localization
Membrane
Light Chain
Gene Name
CD7
Positive Control
CEM cells, HUT-78, Jurkat, Molt-4, or human peripheral blood lymphocytes. Lymph node and tonsil.
Immunogen
Chronic Lymphoid Leukemia cells (CLL)
Alternate Names
T-cell antigen CD7, GP40, T-cell leukemia antigen, T-cell surface antigen Leu-9, TP41, GP40; Leu9; p41; T-cell leukemia antigen; T-cell surface antigen Leu-9; Tp40; TP41

Database Links

Entrez Gene ID
924
Unigene
SwissProt

Additional Information

Clone
B-F12
Human Gene Symbol
CD7
Chromosome Location
17q25.3
Mol. Weight of Antigen
40kDa

Functions

  • Not yet known.

Known Applications & Suggested Dilutions

  • Flow Cytometry (0.5-1ug/million cells)
  • ,Immunofluorescence (0.5-1ug/ml)
  • ,Optimal dilution for a specific application should be determined.

Key References

  • Knapp W et al. eds. Leukocyte typing IV, p341, Oxford University Press, Oxford, 1989.
  • Miwa H, et al biological characteristics of CD7(+) acute leukemia. Leuk Lymphoma. 1996;21:239-44.
  • Rabinowich H, et al. J. Immunol. 1994 153(8):3504-3513.
  • Emara M, et al. A human suppressor T-cell factor that inhibits T-cell replication by interaction with the IgM-Fc receptor (CD7). Hum Immunol. 1989;25(2):87-102.
  • Saxena A, et al. Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am J Hematol. 1998;58(4):278-84.

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.

Reviews

There are no reviews yet.

Be the first to review “CD7 (T-Cell Leukemia Marker)”

Your email address will not be published. Required fields are marked *

Recombinant mouse monoclonal antibodies and recombinant rabbit monoclonals to support your research

Shop Primary Antibodies